Navigation Links
California State Senator Shelia Kuehl's Leadership in Stem Cell Debate Praised and 'Embryonic Stem Cell Profiteers' Criticized by Repair Stem Cell Institute Spokesman
Date:10/8/2008

BANGKOK, Thailand, Oct. 8 /PRNewswire/ -- "California State Senator Shelia Kuehl's leadership role in Senate Bill (SB) 1565 is strong action by a prominent Democrat to bring 'adult stem cell' research to the California Institute of Regenerative Medicine (CIRM) as the viable and credible life science that it is," stated Don Margolis, Chairman of The Repair Stem Cell Institute (RSCI; http://www.RepairStemCells.org), a public service company devoted to educating the public about adult stem cell research and treatments worldwide.

"Adult stem cells are now the 'gold standard' and the only stem cells which have any chance to help people in the next decade," declared Margolis. "But embryonic profiteers and their biotech lobby have politically influenced CIRM, creating a taxpayer-funded embryonic stem cell corporate 'welfare' program that hasn't produced even one possible medical treatment. In fact, because they have no viable path to any embryonic stem cell cures, CIRM has already thrown away $271 million of its $3 billion fund to help finance construction of expensive biotech research facilities for the very institutions which have failed to find a way to implant embryonic cells into humans, or even animals for that matter. And now Governor Arnold Schwarzenegger has vetoed Senator Kuehl's legislation which may have led to adult stem cell research, thus delaying access to long-proven safe and effective therapies for people suffering with 100+ diseases."

According to Margolis, "The only good news out of this situation is that a Democratic leader from the largest state in the union has stood up to the powerful embryonic stem cell lobby and taken a valiant stand for citizens. Senator Kuehl must have done her research about adult stem cells. She may have checked the U.S. Government website (http://www.clinicaltrials.gov) and found for herself a list of over 2000 clinical trials, most of which are already implanting adult stem cells into humans for specific diseases such as cancer, heart, diabetes and others. She most likely saw that embryonic stem cell clinical trials are in the single digits with no human and no diseases involved. Or perhaps, Senator Kuehl and her fellow Democrat legislators visited http://www.RepairStemCells.org/StemCellTreatmentCenters.php for RSCI's comprehensive listing of stem cell treatment centers and doctors/researchers meeting the Institute's 'Standards of Excellence' and are collectively treating 100+ medical conditions."

Margolis had one last word for Gov. Schwarzenegger: "You defended your veto last week by claiming that California voters originally supported only embryonic stem cell research. That's just not true, Governor. They voted for Proposition 71, which specifically included 'adult stem cells'. Read the law, Governor!"

About RSCI:

The Repair Stem Cell Institute LLC (RSCI) is a global public service firm dedicated to educating the public about repair stem cell/adult stem cell research and treatments worldwide. RSCI was founded in April 2008 and is headquartered in Bangkok, Thailand with offices in Dallas, Texas and Washington, D.C.


'/>"/>
SOURCE Repair Stem Cell Institute LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. University of Southern California Receives Cancer Diagnosis System for Detecting Esophageal Dysplasia
2. ALS Therapy Development Institute and California Stem Cell, Inc. Announce Long-Term Scientific Collaboration
3. Phlo Affiliate Announces Significant Distribution Expansion In California
4. Californias International Stem Cell Collaborations Must Be Based on Scientific Merit, Consumer Group Says
5. Controllers Stem Cell Agency Audit Ignores California Agencys Built-in Flaws
6. Nikon Instruments Begins Direct Sales and Technical Support in Southern California and Rocky Mountain Territories
7. ABR-Affinity BioReagents to Participate in the American Association for Cancer Research Meeting in San Diego, California, April 12 - 16, 2008
8. Cord Blood America Says Pennsylvania Joins New York and California in Establishing Educational Programs on the Benefits of Umbilical Cord Blood Storage
9. Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy
10. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
11. Historic Breakthrough in Fighting Childrens Batten Disease as China Stem Cells Give New Lease on Life to 6 Year Old California Boy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on drug ... Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ( ... expected to deliver therapeutic levels of olanzapine for a period of 3 months., “We ...
(Date:2/24/2017)... , Feb. 24, 2017 Provectus Biopharmaceuticals, ... the "Company"), a clinical-stage oncology and dermatology biopharmaceutical ... deadline to participate in its previously announced rights ... of shares of common stock and Series C ... of listed warrants. As previously ...
(Date:2/24/2017)... 2017 Symic Bio, a biopharmaceutical company focused ... of therapeutics, announced today the completion of enrollment for ... disease. The trial will evaluate the safety and efficacy ... reduction of restenosis following angioplasty. "We,re ... SB-030," said Nathan Bachtell , M.D., Chief Medical ...
(Date:2/24/2017)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing and stem ... for the third quarter and first nine months of ... Third Quarter of Fiscal 2017 Highlights ... by 18.6% to RMB200.9 million ($28.9 million). ...
Breaking Biology Technology:
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... 2017   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the latest ... highly flexible and award winning eClinical solution, is now ... is a proven Software-as-a-Service (SaaS) clinical research technology ... but also delivers an entire suite of eClinical tools ...
(Date:2/6/2017)... According to Acuity Market Intelligence, ongoing ... to continue to embrace biometric and digital identification ... Border Control (ABC) eGates and 1436 Automated Passport ... 163 ports of entry across the globe. Deployments ... combined CAGR of 37%. APC Kiosks reached 75% ...
Breaking Biology News(10 mins):